Debashis Biswas,1 Beverly Karabin,2 Debra Turner3 1Neurology, Baptist Memorial Hospital-Memphis, Memphis, TN, USA; 2Cardiovascular Medicine, University of Toledo, Toledo, OH, USA; 3Autonomic Services, Semmes Murphey Clinic, Memphis, TN, USA Abstract ...
Biswas D, Karabin B, Turner D
doaj
Durability of the Clinical Benefit of Droxidopa for Neurogenic Orthostatic Hypotension During 12 Weeks of Open-Label Treatment. [PDF]
Hauser RA +6 more
europepmc +1 more source
Management Strategies for Comorbid Supine Hypertension in Patients with Neurogenic Orthostatic Hypotension. [PDF]
Isaacson SH +3 more
europepmc +1 more source
Mechanism-Based Therapy With Ampreloxetine for Neurogenic Orthostatic Hypotension in Multiple System Atrophy: A Randomized Withdrawal Trial. [PDF]
Freeman R +8 more
europepmc +1 more source
Psychometric validation of a patient-reported single-item assessment of 'Good Day Bad Day' in a neurogenic orthostatic hypotension population treated with droxidopa. [PDF]
François C +5 more
europepmc +1 more source
Elevating blood pressure in neurogenic orthostatic hypotension: Investigating the efficacy and tolerability of rebreathing therapy. [PDF]
Baker JR +7 more
europepmc +1 more source
Elevated plasma neurofilament light chain in isolated REM sleep behavior disorder: Associations with neurogenic orthostatic hypotension and implications for phenoconversion. [PDF]
Calculli A +16 more
europepmc +1 more source
Carbon dioxide for neurogenic orthostatic hypotension in adults: a novel therapy. [PDF]
Baker JR +7 more
europepmc +1 more source
Neurogenic Orthostatic Hypotension in Parkinson Disease-A Narrative Review of Diagnosis and Management. [PDF]
Grosu C +4 more
europepmc +1 more source
Regional cerebral blood flow was measured with the 133-Xenon inhalation method in seven healthy subjects with orthostatic hypotension not due to autonomic failure (i.e. non-neurogenic clinical disorder). Measurements were performed during supine rest and
Edvinsson, Lars, +5 more
core

